• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cowen & Co. initiated coverage on Codex DNA

    7/13/21 6:28:36 AM ET
    $DNAY
    Medical Specialities
    Health Care
    Get the next $DNAY alert in real time by email
    Cowen & Co. initiated coverage of Codex DNA with a rating of Outperform
    Get the next $DNAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DNAY

    DatePrice TargetRatingAnalyst
    3/2/2022Outperform
    Cowen
    10/15/2021Outperform
    Cowen
    7/13/2021$23.00Buy
    Jefferies
    7/13/2021Outperform
    Cowen & Co.
    7/13/2021$30.00Overweight
    Keybanc
    More analyst ratings

    $DNAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cowen resumed coverage on Codex DNA

      Cowen resumed coverage of Codex DNA with a rating of Outperform

      3/2/22 8:41:22 AM ET
      $DNAY
      Medical Specialities
      Health Care
    • Cowen resumed coverage on Codex DNA

      Cowen resumed coverage of Codex DNA with a rating of Outperform

      10/15/21 7:20:31 AM ET
      $DNAY
      Medical Specialities
      Health Care
    • Jefferies initiated coverage on Codex DNA with a new price target

      Jefferies initiated coverage of Codex DNA with a rating of Buy and set a new price target of $23.00

      7/13/21 6:31:09 AM ET
      $DNAY
      Medical Specialities
      Health Care